their getting out.
out for now.
you know if you follow this
market changed now
TTNP: FDA Advisory Panel Recommends Approval of Probuphine By Solid Margin for Second Time…
Zacks Small Cap Research By Zacks Small Cap Research
By: Nisha Hirani, MD & David Bautz, PhD
Sanofi In Talks To Buy PTC Therapeutics ( PTCT )
Paris-based Sanofi SA (ADR)
has restarted negotiations to acquire New Jersey's PTC Therapeutics, Inc.
Société Générale is said to be working on the deal.
Both sides began talks earlier this week after PTC said it received a Refuse to File notice from the FDA regarding its Translarna treatment. The disclosure, which pushed shares down more than 50 percent, was the result of an error and has no material bearing on PTC or Translarna's fundamental outlook, according to the source.
Good Luck !